Brazilian Heart-Prevent Meal - A Pilot Randomized Clinical Trial
16 juli 2012 uppdaterad av: Hospital do Coracao
The Effect of Brazilian Heart Prevent Meal Program Accessible for the Population to Prevent New Cardiovascular Events: A Pilot Randomized Clinical Trial
The purpose of this study is to evaluate the effectiveness of a brazilian cardioprotective diet plan to reduce cardiovascular risk factors of new cardiovascular events.
Studieöversikt
Status
Avslutad
Betingelser
Detaljerad beskrivning
Cardiovascular diseases are the leading cause of mortality in both sexes in Brazil and worldwide.
Modifying risk factors such as diet and lifestyle can prevent most cases of cardiovascular disease.
This pilot trial is based on specific and traditional brazilian food.
The objective is to reduce risk factors such as obesity, high blood pressure,dyslipidemia and diabetes in patients with cardiovascular disease history.
Studietyp
Interventionell
Inskrivning (Faktisk)
122
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Sao Paulo, Brasilien, 04005000
- Hospital do Coracao
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
45 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Any coronary artery disease evidence in the past 10 years; or any ischemic stroke or TIA evidence in the past 10 years; or peripheral arterial disease in the past 10 years; or at least one of the following additional risk factors:
- Diabetes Mellitus; Hypertension; Dyslipidemia; Coronary artery disease family history;
- Asymptomatic carotid artery disease;
- Body mass index> 25 kg/m2 for adults and> 28 kg/m2 for seniors
Exclusion Criteria:
- Neurocognitive or psychiatric condition;
- Life expectancy less than 6 months (eg, metastatic malignancy or other defined as clinical trial investigators).
- Pregnancy or breast feeding.
- Hepatic impairment defined as elevated liver enzymes above three times the upper limit of normal
- Renal impairment defined as creatinine values higher than 1.5 mg/dL.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Group 1
Nutrient profile of the diets used was based on the Brazilian guidelines to cardiovascular disease treatment.The main difference between this group involves a Brazilian version of accessible and energy density concept dietary therapy to cardiovascular diseases.
Furthermore, it explores a set of tools and educational materials that help the patient understand and follow the principles of balanced and healthy diet weekly session with the dietitians which could be in person, by phone or in a gourmet shop.
During attendances at the gourmet shop, patients received tips for eating in restaurants, instruction on label reading and a list of typical foods.
The menus were based on typical foods consumed in Brazil, all foods included in the menu were low-cost and widely available at local markets
|
Nutrient profile of the diets used was based on the Brazilian guidelines to cardiovascular disease treatment.The main difference between this group involves a Brazilian version of accessible and energy density concept dietary therapy to cardiovascular diseases.
Furthermore, it explores a set of tools and educational materials that help the patient understand and follow the principles of balanced and healthy diet weekly session with the dietitians which could be in person, by phone or in a gourmet shop.
During attendances at the gourmet shop, patients received tips for eating in restaurants, instruction on label reading and a list of typical foods.
The menus were based on typical foods consumed in Brazil, all foods included in the menu were low-cost and widely available at local markets
Andra namn:
|
|
Experimentell: Group 2
Group B received the usual dietary therapy to patients with cardiovascular diseases, which had the same nutrient profile as presented in Group A, but customized by the integration of mediterranean typical foods (e.g.
olive oil and nuts).
The difference between groups B and C was the number of sessions with the dietician.
Group B received weekly sessions, which could be in person or by phone, and group C had monthly in person sessions
|
received the usual dietary therapy to patients with cardiovascular diseases, which had the same nutrient profile as presented in Group A, but customized by the integration of mediterranean typical foods (e.g.
olive oil and nuts).
The difference between groups B and C was the number of sessions with the dietician.
Group B received weekly sessions, which could be in person or by phone, and group C had monthly in person sessions
Andra namn:
|
|
Experimentell: Group 3
Group C received the usual dietary therapy to patients with cardiovascular diseases, which had the same nutrient profile as presented in Group A and B, but customized by the integration of mediterranean typical foods (e.g.
olive oil and nuts) at the same of group B. The difference of group C was the number of sessions with the dietician.
That happen monthly in person sessions.
|
received the usual dietary therapy to patients with cardiovascular diseases, which had the same nutrient profile as presented in Group A and B, but customized by the integration of mediterranean typical foods (e.g.
olive oil and nuts) at the same of group B. The difference of group C was the number of sessions with the dietician.
That happen monthly in person sessions.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Systolic Blood Pressure
Tidsram: 12 weeks
|
Change From Baseline in systolic blood pressure
|
12 weeks
|
|
Total Cholesterol
Tidsram: 12 weeks
|
Change From Baseline in total Cholesterol
|
12 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Weight
Tidsram: 12 weeks
|
Change From Baseline in weight
|
12 weeks
|
|
Waist Circumference
Tidsram: 12 weeks
|
Change From Baseline in wais circumference
|
12 weeks
|
|
Blood Glucose
Tidsram: 12 weeks
|
Change From Baseline in blood glucose
|
12 weeks
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Bernardete Weber, PhD, Hospital do Coracao
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 september 2011
Primärt slutförande (Faktisk)
1 december 2011
Avslutad studie (Faktisk)
1 januari 2012
Studieregistreringsdatum
Först inskickad
11 oktober 2011
Först inskickad som uppfyllde QC-kriterierna
13 oktober 2011
Första postat (Uppskatta)
17 oktober 2011
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
19 juli 2012
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
16 juli 2012
Senast verifierad
1 juli 2012
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 01/2011
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .